Chipiron
Develops compact, ultra-low-field MRI systems for accessible breast cancer screening and image-guided therapies
Highlights
- New on EvolcAdded 2026-10-29
About Chipiron
Chipiron is developing compact MRI machines using ultra-low magnetic fields, with a focus on breast cancer screening. Its technology combines cryogenic signal detection, noise cancellation, magnet and gradient design, and AI-based image reconstruction.
The company is based in Paris, where its headquarters and lab are located. It reported a $17 million Series A round in 2025 and is preparing an investigational device and clinical investigation, with commercial launch planned after further development.
Product: Compact ultra-low-field MRI machines and related imaging technology for breast screening.
Jobs at Chipiron
More health & medtech companies
Click&Care
Online-booked home care staffing platform connecting families and care facilities with nursing and care aides in FranceNew on EvolcClininfo
EClinical EDC and eCRF platform for pharma and medical device sponsors running clinical studiesNew on EvolcClinique les Drags
Medical and rehabilitation care for patients recovering after hospitalization or referred from home in Le TouquetNew on EvolcSalary transparentClinsearch
Clinical research and market-access services for pharmaceutical and medical-device sponsors in Europe and internationallyNew on EvolcCodoc
Health data warehouse and research applications for healthcare organizations, research institutes and life science companiesNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Apache
- WordPress
- jQuery